INSULET CORP (PODD) Stock Price, Quote, News and Overview
NASDAQ:PODD - Nasdaq - US45784P1012 - Common Stock - Currency: USD
PODD Quote, Performance and Key Statistics
INSULET CORP
NASDAQ:PODD (1/31/2025, 3:21:45 PM)
278.77
-1.26 (-0.45%)
The current stock price of PODD is 278.77 USD. In the past month the price increased by 6.33%. In the past year, price increased by 44.33%.
PODD Latest News, Press Releases and Analysis
Discover the top S&P500 movers in Friday's pre-market session and stay informed about market dynamics.
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Top S&P500 movers in Thursday's session
Top movers analysis one hour before the close of the markets of S&P500 on 2025-01-16: top gainers and losers in today's session.
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Which S&P500 stocks are moving on Thursday?
NASDAQ:PODD—A High-Growth Stock Gearing Up for Its Next Upward Move.
Is INSULET CORP (NASDAQ:PODD) on the Verge of a Major Breakout as a Strong Growth Stock?
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
PODD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.41 | 222.05B | ||
| ISRG | INTUITIVE SURGICAL INC | 78.22 | 204.21B | ||
| BSX | BOSTON SCIENTIFIC CORP | 43.55 | 151.48B | ||
| SYK | STRYKER CORP | 32.08 | 149.06B | ||
| MDT | MEDTRONIC PLC | 17.3 | 116.44B | ||
| BDX | BECTON DICKINSON AND CO | 18.85 | 71.93B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.19 | 42.83B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.97 | 40.44B | ||
| RMD | RESMED INC | 27.07 | 35.13B | ||
| IDXX | IDEXX LABORATORIES INC | 38.5 | 34.52B | ||
| DXCM | DEXCOM INC | 50.98 | 33.85B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.53 | 25.85B |
Related stock screener links
About PODD
Company Profile
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 3,000 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Company Info
INSULET CORP
100 Nagog Park
Acton MASSACHUSETTS 01720 US
CEO: Shacey Petrovic
Employees: 3000
Company Website: https://www.omnipod.com
Investor Relations: https://investor.insulet.com
Phone: 19786007000
PODD FAQ
What is the stock price of PODD?
The current stock price of PODD is 278.77 USD.
What is the symbol for INSULET CORP stock?
The exchange symbol of INSULET CORP is PODD and it is listed on the Nasdaq exchange.
On which exchange is PODD stock listed?
PODD stock is listed on the Nasdaq exchange.
Is PODD a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PODD, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PODD.
Does PODD stock pay dividends?
PODD does not pay a dividend.
When does PODD stock report earnings?
PODD will report earnings on 2025-02-20, after the market close.
What is the Price/Earnings (PE) ratio of PODD?
The PE ratio for PODD is 77.87. This is based on the reported non-GAAP earnings per share of 3.58 and the current share price of 278.77 USD.
What is the Short Interest ratio of PODD stock?
The outstanding short interest for PODD is 3.86% of its float.
PODD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PODD. When comparing the yearly performance of all stocks, PODD is one of the better performing stocks in the market, outperforming 87.27% of all stocks.
PODD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PODD. PODD has an excellent profitability rating, but there are some minor concerns on its financial health.
PODD Financial Highlights
Over the last trailing twelve months PODD reported a non-GAAP Earnings per Share(EPS) of 3.58. The EPS increased by 129.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 21.22% | ||
| ROA | 13.91% | ||
| ROE | 37.65% | ||
| Debt/Equity | 1.21 |
PODD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to PODD. The Buy consensus is the average rating of analysts ratings from 30 analysts.
For the next year, analysts expect an EPS growth of 24.01% and a revenue growth 24.75% for PODD